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Abstract  25 
 26 
Background: Different abdominal symptoms may signal cancer, but their role is unclear.  27 
 28 
Aim: To examine associations between abdominal symptoms and subsequent cancer 29 
diagnosed in the abdominal region. 30 
 31 
Design and Setting: Prospective cohort study. Surgeries of 493 general practitioners (GPs) in 32 
Norway, Denmark, Sweden, Scotland, Belgium, the Netherlands. 33 
 34 
Method: Over a 10-day period, GPs recorded consecutive consultations; where patients 35 
presented with pre-specified abdominal symptoms, additional data on non-specific symptoms 36 
and features of the consultation were noted. Eight months later, data on all cancer diagnoses 37 
among all study patients in the participating general practices were requested from the GPs. 38 
 39 
Results: Consultations with 61802 patients were recorded. Malignancy was subsequently 40 
diagnosed in 511 patients (0.8%).  Abdominal symptoms were recorded in 6264 (10.1%) 41 
patients.  42 
Among patients with a new cancer in the abdomen, 175 patients were diagnosed 43 
within 6 months after consultation. In a multivariate model, the highest sex and age adjusted 44 
hazard ratio (HR) was for the single symptom ‘Rectal bleeding’ (HR 19.1, 95%CI 8.7-41.7). 45 
PPVs >3% were found for ‘Hematuria, macroscopic’, ‘Rectal bleeding’, ‘Involuntary weight 46 
loss’, with variations according to age and sex. The three symptoms describing irregular 47 
bleeding had particularly high specificity in relation to colorectal, uterine or bladder cancer.   48 
 49 
Conclusion: A patient with undiagnosed cancer may present with symptoms or no symptoms. 50 
Irregular bleeding must always be explained. Abdominal pain occurs in all types of abdominal 51 
cancer. Several symptoms may signal colorectal cancer. The findings are important for how 52 
the GP can think and act to contribute to earlier diagnosis.  53 
 54 
 55 
Keywords: General practice, early diagnosis, cancer, symptoms, proportional hazard model 56 




How this fits in 59 
 60 
A cancer patient can present with no classical signs or symptoms. If a patient presents with an 61 
abdominal symptom, different symptoms have varying levels of association with abdominal 62 
cancer.  63 
 64 
Three symptoms relating to irregular bleeding are highly suspicious for a cancer diagnosis 65 
unless an alternative diagnosis can be confirmed.  66 
 67 
Abdominal pain can be a presenting symptom for all types of cancers of the abdomen, 68 
common or less common. In a common cancer such as colorectal cancer, almost all the 69 
investigated symptoms are potentially relevant. Several combinations of symptoms may 70 
initiate a suspicion about cancer in the abdomen.  71 
 72 
   73 
 74 







About half of cancers are located within the abdominal cavity (1). Abdominal symptoms 80 
(such as pain or bloating) may be associated with cancer. In a previous article, we described a 81 
cohort where approximately 10% of adult patients, consecutively consulting in general 82 
practice in six north European countries, presented with abdominal symptoms. For almost 5% 83 
of symptomatic patients, the symptoms were associated with cancers in the abdomen (2).  84 
 GPs play an active role in the diagnostic process of the majority of cancer patients (3-85 
5). In population studies and in clinical practice, the high frequency of abdominal symptoms 86 
contrasts with the relatively rare diagnosis of a cancer within the abdomen (6, 7). This can 87 
make appropriate referral to more specialised services challenging. Much of the recent 88 
primary care literature has concentrated on elucidating symptoms of more common cancers 89 
such as colorectal cancer (8, 9): this not only reflects the importance of these more frequently 90 
occurring cancers, but also the challenge of collecting sufficient numbers of patients with less 91 
common cancers. Therefore, in addition to studying specific cancers, it may be helpful to 92 
study all cancers located in one anatomical region that present with similar symptom clusters.  93 
This second article based on our prospective patient cohort study focuses on new 94 
cancer diagnoses in the abdominal region, diagnosed within six months of the index 95 
consultation. The aim is to analyse the extent to which various abdominal symptoms are 96 
associated with new cancers of the abdomen, and hence, how predictive of such cancers are 97 






Methods (including variables of interest, power calculations and data analysis techniques) 104 
have been previously described in detail (2). The study was carried out in primary care 105 
practices in Norway, Denmark, Sweden, the Netherlands, Belgium, and Scotland. Overall, 106 
493 participating GPs were recruited through academic institutions active in The Cancer and 107 




Initial registrations 110 
Between 25 February 2011 and 27 July 2011, participating GPs registered consecutive 111 
consultations with patients 16 years of age and older, over ten working days. GPs recorded 112 
sex and date of birth for all patients, and selected abdominal symptoms (Appendix 1) if 113 
presented during the consultation. If abdominal symptoms were recorded, GPs were asked a 114 
further series of symptom-related questions, including non-specific symptoms selected from 115 
medical literature related to cancer.  116 
 117 
Follow up 118 
Participating GPs consented to provide data on all cancer diagnoses (new or recurring) that 119 
occurred after the consultation date for any of their recorded, consulting patients. Eight 120 
months after these consultations, each GP was asked to report all such patients on a 121 
standardized proforma (Appendix 1). It was reasoned that a cancer present during the initial 122 
consultation would usually have presented and been diagnosed within six months, supported 123 
for instance by a study on ovarian cancer (11). The interval is also short enough to increase 124 
the probability that a recorded symptom has something to do with the as yet undiagnosed 125 
cancer (12). With the additional two months before completed proformas were collected, we 126 
assumed that all hospital reports about cancers diagnosed during the six month interval had 127 
reached the GPs.  128 
GPs used electronic records to identify patients and to provide anonymised 129 
information about those patients registered during the initial study period and diagnosed with 130 
cancer during the follow-up period, regardless of whether they had presented with symptoms 131 
during the initial survey. Sex, date of birth, GP identifier and date of consultation were used 132 
for identifying the patients. Two reminders were sent to GPs. The last patient reported with 133 
cancer was diagnosed in April 2012. 134 
We distinguished between ‘abdominal’ and ‘non-abdominal’ types of cancer. In the 135 
abdominal group we included all cancers of digestive organs, female genital organs (except 136 
cancer of the vulva) and urinary organs including testis. Carcinoids, lymphomas, soft tissue 137 
cancers, endocrine tumours and generalized, metastatic cancer were included if they showed 138 
any abdominal sign or symptom. 139 
 140 
Data analysis 141 
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Statistical analyses were performed using SPSS, version 22, and STATA, version 14. The chi-142 
square test was used to examine differences between groups. Association between symptoms 143 
and cancer has been expressed as Cox hazard ratio (HR), in addition to sensitivity/specificity 144 
and likelihood ratio (LR). Positive predictive value (PPV) is presented with age and sex 145 
subgroups. LR in our study expresses the likelihood of a symptom being present when cancer 146 
had been subsequently diagnosed, compared to absence of a cancer diagnosis at follow-up. 147 
HR expresses the hazard for cancer being diagnosed when a patient had presented a symptom, 148 
in relation to when no symptom had been presented. The reference group in our Cox analyses 149 
were patients without abdominal symptoms. Age was the time scale variable for Cox 150 
analyses; entry time was age at consultation and exit time was age at cancer or end of follow-151 
up (30 April 2012). Age adjustment is thus inherent in the model. HR was calculated for 152 
single symptoms and for combinations of symptoms. In the multivariate analyses, HR was 153 
calculated in models where the most frequent symptoms and combinations of symptoms were 154 
adjusted for sex. Due to interaction we applied separate models for each symptom, and for the 155 
combination of symptoms. The proportional hazards assumption was not rejected for patients 156 
diagnosed within 180 days, nor was it rejected for all patients with new abdominal cancer. 157 
Sensitivity analyses for HR comprising the more numerous latter group were therefore 158 
additionally performed. Interaction analyses were also performed for age and each symptom; 159 
no such interactions were found. Cox analyses included only patients with a new cancer. 160 
Analyses presented in tables 2-4 include patients with new abdominal cancer diagnosed 161 
within 180 days after consultation and exclude all other cancer patients (Fig 1). Sensitivity 162 
analyses deal with all patients with new abdominal cancer and with all patients with new 163 
cancer.    164 





Patient profile and cancers detected 170 
Sex and age of patients are shown in Table 1. After corrections for multiple consultations, 171 
61802 patients were included in the cohort. Follow-up forms indicating 640 cancer patients 172 
were received from 315 GPs. After exclusions, 511 patients were included. Of 441 patients 173 
with a new cancer, 251 (56.9%) had abdominal and 190 non-abdominal cancers. Of these 251, 174 
175 patients were diagnosed within six months of their GP consultation. Results presented in 175 
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this paper focus on these 175 patients (Fig 1). The higher proportion of males in relation to 176 
females in the group with abdominal cancers (P<0.001) was consistent with Norwegian 177 
population based data (1). 178 
 179 
Profile of symptoms  180 
Table 2 shows that of 175 patients with new abdominal cancer diagnosed within 6 months, 76 181 
(43.4%) had abdominal symptoms and 39 (22.3%) had multiple abdominal symptoms. For 182 
patients with no cancer, 10.0% had abdominal symptoms and 4.5% multiple abdominal 183 
symptoms. Patients with new non-abdominal cancer had abdominal symptoms in 12.6% of 184 
cases, not different from patients without cancer.    185 
Non-specific symptoms in patients with abdominal symptoms occurred in 29 (38.2%) 186 
of 76 cancer patients (Table 2), and in 24.6% of patients with no cancer. Between patients 187 
with abdominal and non-abdominal types of cancer there was no significant difference in the 188 
recording of non-specific symptoms.  189 
 190 
Measures of association and predictive value of abdominal symptoms in relation to new 191 
abdominal cancer 192 
For the 175 patients with new abdominal cancer diagnosed within six months, table 2 shows 193 
the degree of association with cancer for each symptom, expressed as LR, sensitivity and 194 
specificity, and diagnostic probability expressed as positive predictive value (PPV) of 195 
symptoms. LR was slightly higher for females than males for most symptoms. Any abdominal 196 
symptom had a sensitivity of 43.4%, and more than one abdominal symptom 22.3%. The 197 
three symptoms indicating irregular bleeding, i.e. ‘Rectal bleeding’, ‘Unexpected genital 198 
bleeding’ and ‘Hematuria, macroscopic’ had higher specificity than the other symptoms, 199 
ranging from 99.4 to 99.8%.  200 
Three symptoms reached the cancer referral guideline PPV threshold of 3% in 201 
England (13): ‘Hematuria, macroscopic’ ‘Rectal bleeding’ and ‘Involuntary weight loss’. In 202 
the oldest age groups, several symptoms reached this threshold. The highest PPVs were for 203 
‘Unexpected genital bleeding’ 8.1% in age group 55-74 years, and ‘Hematuria, macroscopic’ 204 
7.9% for patients ≥75 years of age.  205 
Table 3 shows hazard ratios for all single symptoms investigated in a multivariate 206 
model with patients without symptoms as reference group, i.e. ‘Abdominal pain, upper part’, 207 
‘Abdominal pain, lower part’, ‘Constipation’, ‘Rectal bleeding’, and also for the variable 208 
gathering the remaining single symptoms being investigated. The highest HR for a single 209 
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symptom was for ‘Rectal bleeding’ (HR 19.1, 95% CI 8.7-41.7). For the combination of three 210 
or more abdominal symptoms HR was 14.0 (9.1-21.6). HR for males was 1.8 (1.4-2.5), - that 211 
is, if symptoms were recorded, the probability of cancer was higher in males.  212 
Table 4 shows HR for different combinations of symptoms. The reference group is 213 
patients without symptoms. HR is shown for combinations of two symptoms, regardless of 214 
whether there were additional symptoms. The highest HR was for all combination categories 215 
containing ‘abdominal pain, upper part’ + ‘rectal bleeding’, HR 64.2 (26.9-153.1).  216 
Table 5 shows the distribution of recorded symptoms for the main types of new 217 
abdominal cancers. The proportion of symptomatic cases varies for different cancers; there is 218 
a considerable variety of symptoms for most cancers, most pronounced in colorectal cancer. 219 
Abdominal pain was present in all individual cancer types. The three irregular bleeding 220 
symptoms were notable in that they each related strongly to cancer in one type of organ: Of 221 
15 cancer patients with ‘Rectal bleeding’, 14 had either colon or rectal cancer. Of three cancer 222 
patients with ‘Unexpected genital bleeding’, two had uterine body and one cervical cancer. Of 223 
six cancer patients with ‘Hematuria, macroscopic’, three had bladder and one renal cancer. 224 
Altogether, 20 of the 24 cancer patients with irregular bleeding had cancers typically 225 
associated with such bleeding. This degree of specificity was not observed for other 226 
symptoms; for example, only six of 16 cancer patients with ‘Constipation’ and six of 20 227 






Abdominal symptoms were associated with new cancer in the abdominal region – the strength 234 
of these associations confirms the importance of responding appropriately to abdominal 235 
symptoms presenting in primary care (14-16). Conversely, a high proportion of new cancer 236 
diagnoses in the abdomen (56.6 %) did not feature such symptoms during consultations in the 237 
months before diagnosis. This duality underlines the need for a high index of suspicion and 238 
use of clinical judgement, in all phases of an illness episode. Symptoms are important, but on 239 
their own have insufficient sensitivity and specificity to underpin cancer diagnostic decisions. 240 
The diagnostic importance of PPV is considerable: ‘low’ values can still prompt action, 241 
illustrated by the lowering to the 3% threshold in the 2015 update of English referral 242 
guidelines (13), and additional information can increase or decrease the contribution to PPV 243 
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from a symptom (17-19). This is illustrated by the higher PPVs for certain symptoms in 244 
higher age groups.  245 
Our study also provides important information on the relative significance of different 246 
types of symptoms, with high HR for ‘Rectal bleeding’ as a single symptom and the three 247 
‘bleeding’ symptoms showing high specificity for certain types of cancer. Also, the broad 248 
range of cancers affected by abdominal pain and the variety of symptoms in colorectal cancer 249 
are important findings. Three or more abdominal symptoms increased the probability of 250 
cancer, and so did several other combinations of symptoms, especially ‘abdominal pain, upper 251 
part’ and ‘rectal bleeding’, as well as combinations of ‘abdominal pain, upper part’ and a non-252 
specific symptom. Symptoms related to sex-specific types of cancer, like ovarian cancer and 253 
prostatic cancer, could be part of the explanation for sex differences. However, both these 254 
cancers were relatively symptom-poor in another study with cross-sectional registration 255 
before diagnosis (20). The higher proportion of abdominal cancer in males is largely due to 256 
the high number of prostate cancers, and the fact that the most common female cancer, breast 257 
cancer, is not within the abdominal cavity.  258 
  259 
Strength and limitations 260 
The prospective nature of the follow-up ensured that neither the patient nor the GP knew 261 
about the cancer diagnosis at the time of symptom registration, reducing the risk of bias 262 
inherent in retrospective studies. However, symptoms presenting before diagnosis but after 263 
the initial consultation do not show in the cross-sectional data from the consultations. 264 
Consecutive patients were registered, with no selection bias; all common abdominal 265 
symptoms were investigated.  266 
We believe hazard ratios give a complex, but also a rather complete and precise 267 
estimate of the association between symptom and cancer. Sensitivity analyses for all 251 268 
patients with a new abdominal cancer (including those whose cancers were diagnosed > 6 269 
months after the consultation), gave HRs slightly lower than in tables 3-4. This gives support 270 
to the assumption that symptoms recorded more than six months before diagnosis may be less 271 
related to the subsequent cancer. Sensitivity analyses of all new cancer patients consistently 272 
gave slightly higher or lower HR in the expected direction, increasing the reliability of the 273 
estimates.    274 
  275 
Comparison with existing literature 276 
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It has been shown previously that abdominal symptoms commonly precede diagnoses of 277 
abdominal cancers (15, 20). Our study provides a more detailed description of different 278 
symptoms located in the abdominal region. Such symptoms should alert clinicians to the 279 
possibility of abdominal cancers, without forgetting that they also may act as lower risk 280 
symptoms (21) in relation to other cancers.  281 
Higher risk of cancer in men with symptoms as compared to women with similar 282 
symptoms, and the cumulative effect of multiple symptoms, are consistent with findings in a 283 
primary care-based, colorectal cancer study by Lawrenson et al (22). Hippisley-Cox & 284 
Coupland (9, 23) also used a large primary-care database and included information from the 285 
medical history and anemia in addition to combining different abdominal symptoms, 286 
constructing diagnostic algorithms. They analysed hazard ratio and found values not unlike 287 
ours, with especially high values for hematuria in relation to renal tract cancer, and rectal 288 
bleeding in relation to colorectal cancer.  289 
Some of the symptoms we studied have been shown in previous studies to have higher 290 
PPV for specified types of cancer (24, 25), also for specific age groups, consistent with our 291 
findings. GP knowledge about PPV values may have an impact on reducing variation in 292 
referral threshold (26). Colorectal cancer is common and has been studied in primary care 293 
more than most other types of cancer. Hamilton (21, 27) found that less than half of colorectal 294 
cancer patients experienced rectal bleeding and emphasized  the important role of ’low-risk-295 
but-not-no-risk‘ symptoms, which are typically less likely to be referred to ’fast track‘ 296 
diagnosis. Non-specific symptoms have been shown to be associated with rectal bleeding in 297 
colorectal cancer patients (28), and this was the case for several of the patients with rectal 298 
bleeding and colorectal cancer in our study. A study from Sweden found that rectal bleeding 299 
combined with either diarrhea, constipation, change in bowel habit or abdominal pain are 300 
predictors of non-metastatic colorectal cancer, confirming that GPs have an opportunity 301 
window where they can make a difference for patient prognosis (29). 302 
Non-specific symptoms have shown poor association with cancer if occurring alone 303 
(30), but their cancer-diagnostic importance increased if they occurred in combination with 304 
alarm symptoms. Our findings agree with this.  305 
Several studies of the relationship between symptoms and cancer have used a longer 306 
observation period, commonly 12 (22) or 24 (9) months . Our reasons for choosing six 307 
months have been explained in the ‘Method’ section, and the sensitivity analyses performed 308 
seem to suggest that this was a wise approach, giving more precise HRs.  309 
   310 
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Implications for research and practice 311 
A patient with abdominal cancer can present in a range of ways – they may be asymptomatic, 312 
or they may have multiple symptoms. Almost all reasons for encounter require further 313 
questioning and examination before the GP may suspect cancer and refer appropriately. Our 314 
study is relevant for a ‘real life’ consultation in primary care, at a time when abdominal 315 
symptoms can point to many kinds of illness.  316 
All investigated symptoms in our study were associated with an abdominal cancer, 317 
however, different symptoms were related to cancer in different ways. The three ‘bleeding’ 318 
symptoms had particularly high specificity for the individual cancer type most associated with 319 
that symptom. Any of the three irregular bleeding symptoms should therefore lead to further 320 
investigation or referral unless a benign cause can be demonstrated. Even then, bleeding 321 
hemorrhoids do not exclude a more proximal cancer or polyp, and urinary infection with 322 
hematuria may mask bladder cancer.  323 
Abdominal pain as a presenting symptom showed sensitivity for both common and 324 
less common types of abdominal cancer and should not be ignored, in spite of lower 325 
specificity than other symptoms. For colorectal cancer, almost all investigated symptoms 326 
warrant investigation. Several combinations of symptoms call for increased vigilance of GPs. 327 
Our study adds further prospective data to inform cancer diagnostic processes in primary care, 328 
and they encourage continued primary care research about symptoms and cancer.  329 
 330 
  331 
 332 
 333 
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Figure 1: Inclusion and exclusion of patients with cancer
n=67
n=129
*One patient had two new cancers, colon cancer (counted here) plus squamous cell carcinoma 
of lung discovered in hospital. Lung cancer discovered incidentally during work-up.
**One patient had one new (prostate) and one recurrent (bladder) cancer. The prostate cancer 
has been counted here, because this was the new cancer. 
¹ Most patients had a histological verification. The few remaining patients had other 















Previously known, stable or progressive cancer=69
No cancer in spite of reported cancer=4
Precancerous or basal cell ca=31
Uncertainties whether new, recurrent or prevalent = 25
Not part of initial 
registrations




Age in years 16-29 % 30-54 % 55-74 % ≥75 % Total Mean Median Range 25-75 percentile
All patients 8457 14 23144 37 19983 32 10218 17 61802 53 54 16-102 38-68
  Males 2931 12 8365 35 8689 36 3943 17 23928 55 56 16-102 41-69
  Females 5526 15 14779 39 11294 30 6275 16 37874 53 52 16-101 37-68
Patients with symptoms 907 14 2261 36 1992 32 1104 18 6264 54 53 16-100 38-70
  Males 236 11 767 35 792 36 401 18 2196 56 57 16-100 42-70
  Females 671 16 1494 37 1200 30 703 17 4068 53 52 16-100 36-69
Patients with new cancer 2 1 71 14 221 43 217 42 441 69 71 28-96 60-80
  Males 0 0 26 11 104 46 101 43 200 70 71 35-94 62-79
  Females 2 1 45 16 117 42 116 41 241 69 70 28-96 59-80
Patients with new cancer,
diagnosed within 6 months 2 1 47 15 130 42 128 42 307 69 71 28-96 59-80
  Males 0 0 21 15 61 44 58 41 140 69 72 35-94 60-79
  Females 2 1 26 16 69 41 70 42 167 69 71 28-96 59-80
Patients with new abdominal cancer,
diagnosed within 6 months 1 1 23 13 74 42 77 44 175 70 73 28-96 60-80
  Males 0 0 12 13 43 45 40 42 95 70 72 42-94 59-79
  Females 1 1 11 14 31 39 37 46 80 70 74 28-96 61-81
Table 1: Number of patients : all patients, patients with symptoms and patients diagnosed with new cancer after consultation, by sex and different age groups. Mean/median age. 
Table 2. Association between symptoms and new abdominal cancer for 175 patients diagnosed within six months after consultation,  expressed as likelihood ratio (LR), sensitivity, specificity, for all patients.
Also, diagnostic probability expressed as positive predictive value (PPV). LR and PPV with sex  subgroups and PPV with age groups. LR, sensitivity and PPV with 95% confidence interval (CI) for all patients. N=61337 patients. 
Cancer Patients Measures of association Diagnostic probability (PPV)
All Males Females No cancer All Males Females All All All Males Females ≤54 years 55-74 years   ≥75 years
 N=175 N=95 N=80 N=61162 LR 95% CI LR LR Sensitivity 95% CI Specificity PPV (%) 95% CI PPV (%) PPV (%) PPV (%) PPV (%) PPV (%)
Abdominal symptoms
Abdominal pain, upper part 31 15 16 2046 5.3 3.8-7.4 5.2 5.7 17.7  12.4-24.2 96.7 1.5 1.0-2.1 2.0 1.2 0.8 1.7 3.8
Abdominal pain, lower part 20 8 12 2084 3.4 2.2-5.1 3.1 3.9 11.4 7.1-17.1 96.6 1.0 0.6-1.5 1.2 0.8 0.3 1.4 2.3
Constipation 16 6 10 676 8.2 5.1-13.2 7.2 10.0 9.1 5.3- 14.4 98.9 2.3 1.3-3.7 2.8 2.1 1.0 3.0 3.8
Diarrhea 8 3 5 1103 2.5 1.3-5.0 1.7 3.5 4.6 2.0-8.8 98.2 0.7 0.3-1.4 0.7 0.7 0.7 0.3 1.7
Distended abdomen, bloating 17 8 9 1011 5.9 3.7-9.3 5.7 6.4 9.7 5.8-15.1 98.3 1.7 1.0-2.6 2.2 1.3 1.3 1.2 3.9
Increased belching, flatulence 9 5 4 489 6.4 3.4-12.2 7.1 6.0 5.1 2.4-9.5 99.2 1.8 0.8-3.4 2.8 1.3 2.4 1.1 1.4
Acid regurgitation 10 5 5 669 5.2 2.9-9.6 5.3 5.4 5.7 2.8-10.3 98.9 1.5 0.7-2.7 2.1 1.1 0.9 2.6 1.1
Rectal bleeding 15 4 11 385 13.6 8.3-22.3 6.8 21.6 8.6 4.9-13.7 99.4 3.8 2.1-6.0 2.7 4.4 2.1 4.5 6.8
Unexpected genital bleeding 3 0 3 195 5.4 1.7-16.7 - 7.7 1.7 0.4-4.9 99.7 1.5 0.3-4.4 - 1.6 - 8.1 -
Hematuria, macroscopic 6 4 2 141 15.7 6.8-34.5 13.1 14.4 3.4 1.3-7.3 99.8 4.1 1.5-8.7 5.0 3.0 - 5.2 7.9
Increased urinary frequency 10 6 4 732 4.8 2.6-8.8 6.2 3.8 5.8 2.8-10.3 98.8 1.3 0.6-2.5 2.4 0.8 - 1.6 3.3
Other abdominal problems 18 9 9 1116 5.6 3.6-8.8 5.7 5.8 10.3 6.2-15.8 98.2 1.6 0.9-2.5 2.2 1.2 0.3 2.0 4.4
One symptom only 37 14 23 3354
More than one abdominal symptom 39 19 20 2748 5 3.8-6.6 5.2 5.1 22.3 16.4-29.2 95.5 1.4 1.0-1.9 2.0 1.1 0.6 1.9 3.1
Any abdominal symptom 76 33 43 6102 4.4 3.7-5.2 3.9 5.1 43.4 36.0-51.1 90.0 1.2 1.0-1.5 1.5 1.1 0.3 1.6 3.2
No symptom 99 55060
Non-specific symptoms,
given at least one abdominal symptom
Lack of appetite 18 6 12 853 7.4 4.7-11.5 4.8 10.4 10.3 6.2-15.8 98.6 2.1 1.2-3.2 1.9 2.2 0.9 2.9 3.7
Unusual tiredness 17 5 12 812 7.3 4.6-11.6 4.9 10.1 9.7 5.8-15.1 98.7 2.1 1.2-3.3 1.9 2.1 1.1 1.6 4.6
Involuntary weight loss 11 5 6 304 12.7 7.1-22.7 10.9 14.8 6.3 3.2-11.0 99.5 3.5 1.8-6.2 4.2 3.1 2.0 0.9 7.8
More than one non-specific symptom 13 4 9 381 11.6 6.8-19.7 7.4 17.1 7.4 4.0-12.4 99.4 3.3 1.8-5.6 2.9 3.5 2.0 1.7 6.6
Any non-specific symptom 29 10 19 1500 6.8 4.8-9.5 4.9 9.0 16.6 11.4-22.9 97.5 1.9 1.3-2.7 1.9 1.9 0.7 2.2 4.2
Table 3. Number of patients, and sex and age adjusted hazard ratio (HR) for some important abdominal symptoms in relation to new abdominal cancer, diagnosed within 6 months after consultation. 
Multivariate Cox analysis with mutually exclusive groups *. Patients without symptoms as reference group. HR is shown for single symptoms and for multiple symptoms, 
regardless of whether there also were non-specific symptoms . N = 61337 patients  
New abd cancer diagnosed within 6 months Males Females No cancer  
Symptoms N=175 N=95 N=80 N=61162 HR 95% CI HR males HR females
Model with groups without overlap:
No abdominal symptoms 99 62 37 55060 1.0 Ref. 1.0 1.0
Abdominal pain upper part, as single symptom 5 1 4 663 4.8 1.9-11.8 1.9 8.5
Abdominal pain lower part, as single symptom 5 2 3 608 5.8 2.4-14.3 3.8 9.1
Constipation, as single symptom 3 0 3 141 6.8 2.1-21.8 17.3
Rectal Bleeding, as single symptom 7 0 7 191 19.1 8.7-41.7 49.5
Any other single abdominal symptoms, grouped together 17 11 6 1751 4.7 2.8-7.9 4.9 4.3
Two  abdominal symptoms 12 8 4 1574 4.6 2.5-8.5 5.6 3.5
Three or more abdominal symptoms 27 11 16 1174 14.0 9.1-21.6 10.2 21.1
     Male sex 95 80 1.8 1.4-2.5
* The model includes mutually exclusive groups (i.e. with no overlap, one patient cannot be part of more than one group) containing  selected single symptoms, any other remaining symptoms grouped together, 
combinations of two symptoms, and of three or more symptoms. 
Table 4. Number of patients and sex adjusted hazard ratio (HR) * for the most important combinations of two symptoms, with or without additional symptoms. 
Multivariate Cox analyses, with each row representing one separate model. Patients without symptoms as reference group. N = 61337 patients
New abd cancer diagnosed within 6 months Males Females No cancer
Symptom combinations N=175 N=90 N=85 N=61162 HR 95% CI HR Males HR Females
No abdominal symptoms 99 62 37 55060 1.0 Ref. 1.0 1.0
Abdominal pain upper part + lower part 7 3 4 543 8.1 3.7-17.6 6.7 11.1
Abdominal pain upper part + constipation 7 4 3 194 22.2 10.1-48.5 19.8 26.1
Abdominal pain upper part + diarrhea 5 3 2 361 11.5 4.6-28.8 17.6 8.8
Abdominal pain upper part + distended abdomen 11 5 6 458 15.0 8.0-28.3 12.4 19.9
Abdominal pain upper part + increased belching 9 5 4 263 23.2 11.4-46.7 21.1 26.1
Abdominal pain upper part + acid regurgitations 8 4 4 440 13.3 6.3-27.6 16.6 12.9
Abdominal pain upper part + rectal bleeding 6 3 3 47 64.2 26.9-153.1 57.5 100.5
Abdominal pain upper part + other abdominal problem 7 3 4 200 22.3 10.2-48.8 19.6 24.2
Abdominal pain lower part + constipation 7 3 4 296 12.6 5.8-27.5 9.2 19.7
Abdominal pain lower part + distended abdomen 6 3 3 449 7.9 3.4-18.0 7.1 9.6
Abdominal pain upper part + lack of appetite 14 6 8 457 17.2 9.7-30.5 14.9 22.4
Abdominal pain upper part + unusual tirednesss 10 4 6 342 16.8 8.6-32.8 13.4 23.3
Abdominal pain upper part + unexpected weight loss 5 3 2 130 21.6 8.6-54.2 30.8 18.2
* Criteria for analyses: All combinations with at least 50 patients presenting the combination, and at least 5 cases of cancer with that combination
Table 5. Number of symptoms recorded at consultation in the main types of new abdominal cancer, diagnosed within 6 months after consultation
Ca = Cancer
Cancer patients Oesophagal ca Stomach ca Pancreatic ca Primary hepatic ca Biliary ca Colon ca Rectal ca Cervical ca Uterine body ca Ovarian ca Renal ca Bladder ca Prostate ca
Number of patients 175 5 6 9 7 3 37 17 6 8 4 12 17 34
Hereof number of patients with symptom(s) recorded at consultation 76 * 3 5 2 3 1 22 12 2 3 3 4 4 8
Abdominal symptoms
Abdominal pain, upper part 31 2 4 2 1 1 7 5 1 1 2 2
Abdominal pain, lower part 20 1 6 3 1 1 2 1 2
Constipation 16 1 1 6 4 1 1
Diarrhea 8 4 2 1
Distended abdomen, bloating 17 1 2 6 4 1 1
Increased belching, flatulence 9 1 2 1 2 2 1
Acid regurgitation 10 2 1 1 4 1 1
Rectal bleeding 15 1 8 6
Unexpected genital bleeding 3 1 2
Hematuria, macroscopic 6 1 1 3
Increased urinary frequency 10 1 1 1 1 2 3
Other abdominal problems 18 3 3 2 5 1 1 2
Non-specific symptoms, given at least one abdominal symptom
Lack of appetite 18 2 1 1 1 4 2 1 1
Unusual tiredness 17 2 1 1 1 5 2 1 1 2
Involuntary weight loss 11 1 1 1 3 2 1 1
* The total number of patients in this column is for some symptoms slightly higher than the sum of the other columns, because a few rare or more undetermined types of abdominal cancer have not been included in the table
